Skip to main content

Closed

NAGE: Niagen Bioscience Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin8.5%

ROIC11.4%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio4.61×

Valuation

Unrated

P/E ratio14.5×

Niagen Bioscience Inc

NAGENASDAQ Capital Market·USD·Closed

Niagen Bioscience Inc

NAGENASDAQ·USD·Closed

$3.40

+2.41%

$3.40

+$0.08 (2.41%)

52W Range

3thpctl

Volume

0.76×avg

Mkt Cap

270.79MUSD

P/E

14.5TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.76×avg

Market Cap

270.79MUSD

P/E Ratio

14.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings